Cholangiocarcinoma
PJ Brindley, M Bachini, SI Ilyas, SA Khan… - Nature reviews Disease …, 2021 - nature.com
Cholangiocarcinoma (CCA) is a highly lethal adenocarcinoma of the hepatobiliary system,
which can be classified as intrahepatic, perihilar and distal. Each anatomic subtype has …
which can be classified as intrahepatic, perihilar and distal. Each anatomic subtype has …
[HTML][HTML] Mechanoresponsive metabolism in cancer cell migration and metastasis
Altered tissue mechanics and metabolism are defining characteristics of cancer that impact
not only proliferation but also migration. While migrating through a mechanically and …
not only proliferation but also migration. While migrating through a mechanically and …
High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer
F Boyaval, H Dalebout, R Van Zeijl, W Wang… - Cancers, 2022 - mdpi.com
Simple Summary The detection of colorectal cancer (CRC) at an early stage is increasing
due to the implementation of screening programs. Local excision of early CRC is potentially …
due to the implementation of screening programs. Local excision of early CRC is potentially …
Global mapping of glycosylation pathways in human-derived cells
Glycans are one of the fundamental classes of macromolecules and are involved in a broad
range of biological phenomena. A large variety of glycan structures can be synthesized …
range of biological phenomena. A large variety of glycan structures can be synthesized …
An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry
N-glycosylation is an abundant post-translational modification of most cell-surface proteins.
N-glycans play a crucial role in cellular functions like protein folding, protein localization, cell …
N-glycans play a crucial role in cellular functions like protein folding, protein localization, cell …
Targeting glycans for CAR therapy: The advent of sweet CARs
Z Raglow, MK McKenna, CL Bonifant, W Wang… - Molecular Therapy, 2022 - cell.com
Chimeric antigen receptor (CAR) T cell therapy has created a paradigm shift in the treatment
of hematologic malignancies but has not been as effective toward solid tumors. For such …
of hematologic malignancies but has not been as effective toward solid tumors. For such …
The interaction between DNMT1 and high‐mannose CD133 maintains the slow‐cycling state and tumorigenic potential of glioma stem cell
Y Wei, Q Chen, S Huang, Y Liu, Y Li, Y Xing… - Advanced …, 2022 - Wiley Online Library
The quiescent/slow‐cycling state preserves the self‐renewal capacity of cancer stem cells
(CSCs) and leads to the therapy resistance of CSCs. The mechanisms maintaining CSCs …
(CSCs) and leads to the therapy resistance of CSCs. The mechanisms maintaining CSCs …
The complexity and dynamics of the tissue glycoproteome associated with prostate cancer progression
R Kawahara, S Recuero, M Srougi, KRM Leite… - Molecular & Cellular …, 2021 - ASBMB
The complexity and dynamics of the immensely heterogeneous glycoproteome of the
prostate cancer (PCa) tumor microenvironment remain incompletely mapped, a knowledge …
prostate cancer (PCa) tumor microenvironment remain incompletely mapped, a knowledge …
Serine/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of β-catenin
CQ Gao, ZZ Chu, D Zhang, Y Xiao, XY Zhou, JR Wu… - Oncogene, 2023 - nature.com
Cholangiocarcinoma (CCA) is a highly heterogeneous and metastatic malignancy with a
poor prognosis even after curative hepatectomy. Studies exploring its pathogenesis and …
poor prognosis even after curative hepatectomy. Studies exploring its pathogenesis and …
[HTML][HTML] Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
MK McKenna, A Ozcan, D Brenner… - … for immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Cell therapies for solid tumors are thwarted by the hostile tumor
microenvironment (TME) and by heterogeneous expression of tumor target antigens. We …
microenvironment (TME) and by heterogeneous expression of tumor target antigens. We …